Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Journal Articles (1)

Journal

Investigative Ophthalmology & Visual Science (1)

Article Type

Immunology and Microbiology (1)

Topics

Immunology and Microbiology (1)

Tags

behcet syndrome (1)
cd56 antigens (1)
cyclosporine (1)
cytokine (1)
down-regulation (1)
interleukin-4 (1)
neural cell adhesion molecules (1)
prednisone (1)
t-lymphocytes (1)
uveitis (1)

Specify Date Range

From: To: Apply

Showing 1 – 1 of 1

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Immunology and Microbiology July 2005

Down-Regulation of IFN-γ–Producing CD56 + T Cells after Combined Low-Dose Cyclosporine/Prednisone Treatment in Patients with Behçet’s Uveitis

PDF

Jae Kyoun Ahn; Jong-Mo Seo; Jeesuk Yu; Frederick Sehwoong Oh; Hum Chung; Hyeong Gon Yu
TAGS: behcet syndrome, cd56 antigens, cyclosporine, cytokine, neural cell adhesion molecules, prednisone, t-lymphocytes, uveitis, down-regulation, interleukin-4
Invest. Ophthalmol. Vis. Sci.. 2005; 46(7):2458-2464. doi: https://doi.org/10.1167/iovs.04-0792

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2023 Association for Research in Vision and Ophthalmology.

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept